Antrum Size, Glucagon-like Peptide 1 Levels and Glycemic Control After Sleeve Gastrectomy in Morbid Obese Diabetic Adolescents
NCT04388059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2020-05-14
Summary
Childhood obesity can adversely affect every organ and often has serious consequences. Compare the effect of transection at 2cm vs at 5cm from the pylorus during laparoscopic sleeve gastrectomy on the postoperative weight loss, glucagon-like peptide 1 levels and the glycemic control in morbid obese diabetic adolescents.
Conditions
- Adolescent Obesity
Interventions
- PROCEDURE
-
Laparoscopic sleeve gastrectomy
Laparoscopic sleeve gastrectomy at 2 and 5 cm from the pylorus on the postoperative weight loss, GLP1 levels and the glycemic control in morbid obese diabetic adolescents.
Sponsors & Collaborators
-
Tanta University
lead OTHER
Eligibility
- Min Age
- 12 Years
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
More Related Trials
-
Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists
NCT06003985 ·Status: COMPLETED
-
Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes
NCT04782999 ·Status: COMPLETED ·Phase: NA
-
Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176890 ·Status: UNKNOWN ·Phase: NA
-
To Determine Tolerability to Glucagon Infusion in Obese Subjects
NCT02817659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Effect of Liraglutide on the GIT
NCT04008290 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of GLP-1 on the Inhibition of Glucagon Secretion
NCT01507597 ·Status: COMPLETED ·Phase: NA
-
GLP-1 Signaling in Truncally Vagotomized Subjects
NCT02940184 ·Status: UNKNOWN ·Phase: NA
-
The Importance of Ghrelin for Glucose Metabolism After Sleeve Gastrectomy
NCT05189353 ·Status: COMPLETED ·Phase: NA
-
Gastric Volume in Patients on GLP-1 Medications
NCT05903482 ·Status: COMPLETED
-
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
NCT03139305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial
NCT00975533 ·Status: UNKNOWN ·Phase: PHASE3
-
Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
NCT00655603 ·Status: UNKNOWN ·Phase: NA
-
Glucagon-like Peptide 2 - a Glucose Dependent Glucagonotropic Hormone?
NCT03954873 ·Status: COMPLETED ·Phase: NA
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA
-
Postprandial Gut Hormone Responses in Patients With Type 1 Diabetes Mellitus
NCT04430946 ·Status: UNKNOWN ·Phase: NA
-
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
NCT02584582 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
The Effect of Insulin-induced Hypoglycaemia on Gut-derived Glucagon Secretion (Px-Hypo)
NCT04064203 ·Status: COMPLETED ·Phase: NA
-
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795 ·Status: UNKNOWN
-
The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
NCT01843855 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery
NCT07212868 ·Status: RECRUITING ·Phase: PHASE1
-
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
NCT01803451 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
NCT01449019 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
NCT02669524 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
NCT00993720 ·Status: COMPLETED ·Phase: PHASE2/PHASE3